弥漫性大B细胞淋巴瘤的新动态预后指数:国际代谢预后指数
研究基于五项已发表的新诊断弥漫性大B细胞淋巴瘤研究中的PET扫描和临床数据,比较代谢肿瘤体积(MTV)与生存的最佳统计关系,并与国际预后指数(IPI)及其组分比较以构建最佳预后模型。结果显示MTV与生存的最佳关系为线性样条模型(节点位于中位MTV值307.9 cm³),MTV联合年龄和分期的模型优于IPI,并能更好定义高危组。
要点
- MTV与生存的最佳关系为线性样条模型,节点位于中位MTV值307.9 cm³。
- MTV联合年龄和分期的模型优于IPI,3年PFS 46.3% vs 58.0%,3年OS 51.5% vs 66.4%。
- 该新预后指数可估计个体患者生存概率。
核心结论
- 提出一种使用MTV、年龄和分期的新预后指数,其优于IPI并能实现个体化患者结局估计。
研究设计与样本
- 纳入五项已发表的新诊断弥漫性大B细胞淋巴瘤研究中的PET扫描和临床数据。
- 比较MTV的不同变换与3年无进展生存(PFS)和总生存(OS)的关系以确定最佳关系。
- 将MTV与IPI分类及单个组分比较以构建最佳模型。
- 使用Kaplan-Meier分析将患者分为三组:最高风险10%、中等风险30%、最低风险60%。
- 使用四项研究作为测试集、第五项研究作为验证集进行验证,并重复五次。
主要发现
- MTV与生存的最佳关系为线性样条模型,一个节点位于中位MTV值307.9 cm³。
- MTV对PFS和OS的预测优于IPI。
- 最佳模型将MTV与年龄作为连续变量、单个分期作为I-IV期相结合。
- MTV-年龄-分期模型优于IPI,且能更好定义高危组:新模型与IPI的3年PFS分别为46.3%和58.0%,3年OS分别为51.5%和66.4%。
- 推导出回归公式以估计个体患者生存概率。
关键数值与推荐
- 中位MTV值为307.9 cm³。
- 高危组3年PFS:新模型46.3% vs IPI 58.0%。
- 高危组3年OS:新模型51.5% vs IPI 66.4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Baseline metabolic tumor volume (MTV) is a promising biomarker in diffuse large B-cell lymphoma (DLBCL). Our aims were to determine the best statistical relationship between MTV and survival and to compare MTV with the International Prognostic Index (IPI) and its individual components to derive the best prognostic model. METHODS: PET scans and clinical data were included from five published studies in newly diagnosed diffuse large B-cell lymphoma. Transformations of MTV were compared with the primary end points of 3-year progression-free survival (PFS) and overall survival (OS) to derive the best relationship for further analyses. MTV was compared with IPI categories and individual components to derive the best model. Patients were grouped into three groups for survival analysis using Kaplan-Meier analysis; 10% at highest risk, 30% intermediate risk, and 60% lowest risk, corresponding with expected clinical outcome. Validation of the best model was performed using four studies as a test set and the fifth study for validation and repeated five times. RESULTS: The best relationship for MTV and survival was a linear spline model with one knot located at the median MTV value of 307.9 cm3. MTV was a better predictor than IPI for PFS and OS. The best model combined MTV with age as continuous variables and individual stage as I-IV. The MTV-age-stage model performed better than IPI and was also better at defining a high-risk group (3-year PFS 46.3% v 58.0% and 3-year OS 51.5% v 66.4% for the new model and IPI, respectively). A regression formula was derived to estimate individual patient survival probabilities. CONCLUSION: A new prognostic index is proposed using MTV, age, and stage, which outperforms IPI and enables individualized estimates of patient outcome.
引用
- Mikhaeel NG, Heymans MW, Eertink JJ, et al. Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index. J Clin Oncol. 2022. PMID: 35357901. doi:10.1200/JCO.21.02063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。